Acquired immunodeficiency syndrome (AIDS) is caused by human immunodeficiency virus (HIV) infection and is
primarily a disease of the immune system (4) . Characteristic laboratory features of AIDS include lymphopenia, a decreased number of CD4 lymphocytes, and reversal of the ratio of CD4 (helper/inducer) to CD8 (suppressor/cytotoxic) lymphocytes (8) . In addition, patients with AIDS-related complex or AIDS have been reported to have increased levels of soluble interleukin-2 (IL-2) receptors, soluble CD8, ,32-microglobulin, lysozyme, acid-labile human leukocyte interferon, and thymosin a in serum (1, 11, 15) .
Neopterin (6-D-erythro-trihydroxypropylpterin) is a lowmolecular-weight compound derived from GTP (5) . The cytokine IL-1 occurs as two biochemically distinct proteins, namely IL-1 alpha and IL-1 beta (2) . Each IL-1 is encoded by a separate gene. These two forms share 26% amino acid sequences, bind the same receptor on target cells, and exhibit an identical broad spectrum of biological activities on a variety of cells (2, 7, 12, 18) . The monocyte-macrophage is an important source of neopterin, IL-1 alpha, and IL-1 beta (2, 5, 12, 18 (iii) IL-1 beta assay. IL-1 beta was quantitated by using the Cistron IL-1 beta ELISA kit (Cistron Biotechnology, Inc., Pine Brook, N. J.). Serum samples and standards were added to microdilution plate wells coated with monoclonal antibody specific for IL-1 beta and incubated. Then, polyclonal rabbit anti-IL-1 beta was added to the wells. After RESULTS Neopterin values in normal controls, IVDA, homosexuals, and patients with lymphadenopathy or AIDS are given in Table 1 and depicted in Fig. 1 . The mean neopterin level in the sera of normal controls was 1.19 0.12 ng/ml (mean ± standard error of the mean) compared with 1.75 ± 0.21 ng/ml in the sera of HIV-seronegative IVDA and 1.76 ± 0.14 ng/ml in the sera of HIV-seronegative homosexuals. This increase in the mean neopterin levels in the sera of HIV-seronegative IVDA and HIV-seronegative homosexuals is statistically significant. Similar statistically significant increases were observed in the sera of HIV-seropositive IVDA, homosexuals, and patients with lymphadenopathy. The mean neopterin level in the sera of patients with AIDS was 18.6 + 2.10 ng/ml, and this increase is highly significant.
IL-1 alpha levels in the sera of normal controls and HIV-seronegative and HIV-seropositive groups are shown in Table 1 and depicted in Fig. 2 . The mean IL-1 alpha level in the sera of normal controls was 359 + 146 pg/ml compared with 581 + 44 pg/ml in the sera of HIV-seronegative IVDA. This increase is statistically significant. IL-1 alpha levels in the sera of HIV-seropositive IVDA and HIV-seropositive and HIV-seronegative homosexuals were decreased significantly compared with control values, whereas IL-1 alpha levels in the sera of patients with lymphadenopathy or AIDS were not significantly different from control values.
IL-1 beta levels in the sera of HIV-seronegative and HIV-seropositive groups are given in Table 1 and shown in Fig. 3 . The mean IL-1 beta levels for all groups were not significantly different from control values, except for the HIV-seronegative homosexual group; for this group, the level of IL-1 beta in serum was significantly lower than the control value. Whereas there were measurable levels of IL-1 beta in the sera of 42% of controls, the levels in the patient groups were 34% for HIV-seronegative asymptomatic IVDA, 39% for HIV-seropositive IVDA, 8% for HIV-seronegative homosexuals, 11% for HIV-seropositive homosexuals, 16% for patients with lymphadenopathy, and 63% for patients with AIDS.
Both HIV-seronegative and HIV-seropositive subjects had much higher levels of IL-1 alpha than IL-1 beta in their circulations.
DISCUSSION
The primary immunologic defect in subjects infected with HIV is depletion of the CD4 (helper/inducer) lymphocyte subset, leading to lymphopenia, decreased CD4/CD8 ratios, and decreased T-cell and B-cell function (4, 8) . Other laboratory parameters which increase in HIV-infected persons include 2-microglobulin levels in serum and urine, soluble IL-2 receptors, HIV P24 antigen levels in serum, acid-labile alpha interferon levels in serum, thymosin a and thymosin 4 levels in serum, and soluble CD8 and neopterin levels in serum and urine (1, 5, 8, 11, 15, 16) . The results of the present study demonstrate that the neopterin levels in serum increase in subjects in groups at risk for HIV infection as well as in patients infected with HIV. However, monocyte function is defective in patients with AIDS both in random locomotion and chemotaxis and in phagocytosis (13, 14, 17) , although Murray et al. (10) reported that the antimicrobial function of monocytes in AIDS patients was intact and could be stimulated with gamma interferon. Neopterin levels are elevated in the serum and urine of patients with AIDS-related complex and AIDS (5, 6, 8) , and neopterin has recently been suggested as one of four laboratory markers that may be used to predict which patients will progress to AIDS after HIV infection (9). Fuchs et al. (6) (2, 12, 18) . IL-1 has been reported to modulate the proliferation, maturation, and biologic activity of T lymphocytes, B lymphocytes, and other tissue cells (12) . Circulating IL-1 alpha levels were much higher than circulating IL-1 beta levels, and IL-1 alpha appears to be the predominant form in the circulation. Although all but four subjects (99%) produced detectable levels of IL-1 alpha, only 34% of the subjects produced detectable levels of IL-1 beta in their circulation. The predominance of IL-1 alpha in serum might be due to preferential synthesis of IL-1 alpha over IL-1 beta by some cell types.
Circulating levels of IL-1 have been reported to increase during some infections and inflammatory diseases, whereas decreased production has been observed in patients with metastatic tumors and nutritional deficiencies (2 
